There was a problem with saving your item s for later. You can go to cart and save for later there. Average rating: 0 out of 5 stars, based on 0 reviews Write a review. O R Hommes. Tell us if something is incorrect. Add to Cart. Free delivery. Arrives by Monday, Oct 7. Or get it by Fri, Sep 27 with faster delivery.
Pickup not available. About This Item We aim to show you accurate product information.
Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis - prehealesavis.tk
Manufacturers, suppliers and others provide what you see here, and we have not verified it. See our disclaimer. Specifications Series Title Topics in Neuroscience. Customer Reviews.
Write a review. See any care plans, options and policies that may be associated with this product. Email address. Please enter a valid email address. Walmart Services. Therefore, for the purposes of this paper, articles written within the last decade were considered for review. Economic burden of multiple sclerosis: A systematic review of the literature. Pharmacoeconomics ; Gadoth N. Multiple sclerosis in children.
Brain Dev ; Eliades MN. The rehabilitation of the multiple sclerosis patient. Dis Mon ; The use of complementary and alternative medicine in patients with multiple sclerosis: A longitudinal study. Complement Ther Med ; Multiple sclerosis presenting initially with a worsening of migraine symptoms. J Headache Pain ; Childhood multiple sclerosis: A review. The natural history of multiple sclerosis with childhood onset.
Clin Neurol Neurosurg ; Multiple sclerosis in children: Clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol ; Maillart E, Papeix C.
Treatment of multiple sclerosis: New approaches to treat case by case. Rev Prat ; The genetics of multiple sclerosis: Review of current and emerging candidates. Appl Clin Genet ; Lassmann H. Pathology and disease mechanisms in different stages of multiple sclerosis. J Neurol Sci ; Cohen JA. Mesenchymal stem cell transplantation in multiple sclerosis. Boissy A, Fox RJ. Current treatment options in multiple sclerosis. Curr Treat Options Neurol ; Rieckmann P. Neurodegeneration and clinical relevance for early treatment in multiple sclerosis.
Int MS J ; Neurodegeneration in autoimmune CNS inflammation.
Exp Neurol ; The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain ; Multiple sclerosis: Is there neurodegeneration independent from inflammation? MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy.
J Neurol Neurosurg Psychiatry ; Wilkins A, Scolding N. Protecting axons in multiple sclerosis. Mult Scler ; Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis. J Neuroimmunol ; Bermel A, Inglese M. Neurodegeneration and inflammation in MS: The eye teaches us about the storm. Neurology ; Racke MK.
Immunopathogenesis of multiple sclerosis. Ann Indian Acad Neurol ; Neuroprotection in multiple sclerosis: A therapeutic challenge for the next decade.
- Assessment and Counselling: Theory, Process and Decision-Making.
- Fear and trembling ; and, the sickness unto death;
- Child Care and Development.
Pharmacol Ther ; Neuroinflammation in multiple sclerosis: Evidence for autoimmune dysregulation, not simple autoimmune reaction. Lassmann H, van Horssen J. The molecular basis of neurodegeneration in multiple sclerosis. FEBS Lett ; Oxidative damage in multiple sclerosis lesions. Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease. Current and emerging therapies in multiple sclerosis: A systematic review. Ther Adv Neurol Disord ; Rice CM.
source link Disease modification in multiple sclerosis: An update. Pract Neurol ; Comi G. Disease-modifying treatments for progressive multiple sclerosis. Perumal J, Khan O. Emerging disease-modifying therapies in multiple sclerosis.